Sanofi (WBO:SANO) FFO


WBO:SANO Sanofi SA WBO:SANO
74 GF Score
Price €74.95
GF Value €106.79
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Sanofi FFO?

FFO (Funds from operations) only applies to REITs.

WBO:SANO
74GF Score
Sanofi SA WBO:SANO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sanofi (WBO:SANO) Overvalued in 2026?

Based on GuruFocus' analysis, Sanofi stock appears to be undervalued. The current stock price of €74.95 is trading 29.8% below its estimated GF Value™ of €106.79. GuruFocus considers Sanofi to be Possible Value Trap.

Key valuation signals for WBO:SANO:

  • FFO:
  • GF Value™: €106.79 vs. price of €74.95 (29.8% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the WBO:SANO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sanofi Business Description

Address 46, Avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
74GF Score

Get the complete analysis for WBO:SANO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€74.95
Price
€106.79
GF Value